Home

Loading...

Follow 1st Thoracic Oncology Symposium 2025 for Live Updates

Welcome Message

It is our great pleasure to welcome you to the 1st Thoracic Oncology Symposium, taking place on 28-29 November in Cleaveland Clinic Abu Dhabi.

As the burden of thoracic malignancies continues to rise globally, the need for multidisciplinary collaboration and innovation has never been greater. This symposium aims to provide a comprehensive platform to explore the latest advances in the diagnosis, treatment, and research of thoracic cancers — from lung, mediastinal and pleural tumors to complex surgical interventions and emerging local and systemic therapies.

Our scientific program features high-impact lectures, expert panels, and interactive sessions led by internationally recognized speakers. It is designed to foster collaboration, stimulate discussion, and inspire excellence in thoracic oncology. We are proud to organize this inaugural edition at Cleveland Clinic Abu Dhabi, and we believe it will serve as a unique opportunity to network, exchange knowledge, and strengthen collaborations across regions and specialties.

We look forward to welcoming you to Abu Dhabi for a meaningful and engaging exchange of ideas — and to shaping the future of thoracic cancer care together.

Best regards,

Andres Obeso
Andres Obeso Activity Director of the 1st Thoracic Oncology Symposium

Target Audience

Learning Objectives

10 Dec

Analyse the application of personalised lung cancer care by critically evaluating the latest NCCN guidelines, tumour molecular profiling, and MDT approaches to develop tailored treatment plans that optimise patient outcomes.

10 Dec

Evaluate the efficacy of advanced therapies, including stereotactic body radiotherapy (SBRT), minimally invasive surgical approaches, oncological targeted therapies etc. through the assessment of real case studies to determine their impact on early-stage and complex lung cancer cases.

10 Dec

Synthesise regional and global best practices in lung cancer care by fostering collaboration and networking, enabling attendees to apply these insights to enhance the standard of care and patient access to innovative treatments across the GCC.

Committee

Subscribe to Our
Newsletter

ACCME Accreditation Statement

Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ACCME Credit Designation Statement

Cleveland Clinic Abu Dhabi designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits TM. Physicians should obtain only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE AND CONFLICT OF INTEREST

The planning committee, faculty and others in control of content (either individually or as a group) have disclosed relevant financial relationships with ineligible companies. All relevant financial relationships have been reviewed and mitigated in accordance with ACCME standards.